Spatial mapping of dextran sodium sulphate‐induced intestinal inflammation and its systemic effects
The FASEB Journal · 28.02.2025 · 39 (4)
DOI: 10.1096/fj.202402780r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 24.02.2025. Verfasst von Lauren Adams und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Infection and Immunology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Dextran Sulfate, Inflammation, Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a multifactorial disease, and patients frequently experience extraintestinal manifestations affecting multiple sites. Causes of systemic inflammation remain poorly understood, but molecules originating from the intestine likely play a role, with microbial and host small molecules polarizing host immune cells towards a pro‐ or anti‐inflammatory phenotype. Using the dextran sodium sulfate (DSS) mouse model, which mimics the disrupted barrier function, microbial dysbiosis, and immune cell dysregulation of IBD, we investigated metabolomic and phenotypic changes at intestinal and systemic sites. Using spatial biology approaches, we mapped the distribution and relative abundance of molecules and cell types across a range of tissues, revealing significant changes in DSS‐treated mice. Molecules identified as contributing to the statistical separation of treated from control mice were spatially localized within organs to determine their effects on cellular phenotypes through imaging mass cytometry. This spatial approach identified both intestinal and systemic molecular drivers of inflammation, including several not previously implicated in inflammation linked to IBD or the systemic effects of intestinal inflammation. Metabolic and inflammatory pathway interplay underpins systemic disease, and determining drivers at the molecular level may aid the development of new targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Infection and Immunology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
- Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
ORCID-Profile: Orhan Rasid, Heather Hulme, Tezz Quon, Richard Burchmore, Simon Milling, Richard J A Goodwin, Daniel M Wall
Förderung
- UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Adams, L., Rasid, O., Hulme, H., Quon, T., Burchmore, R., Milling, S., Goodwin, R. J. A., & Wall, D. M. (2025). Spatial mapping of dextran sodium sulphate‐induced intestinal inflammation and its systemic effects. The FASEB Journal, 39(4). https://doi.org/10.1096/fj.202402780r
Vancouver
Adams L, Rasid O, Hulme H, Quon T, Burchmore R, Milling S, et al. Spatial mapping of dextran sodium sulphate‐induced intestinal inflammation and its systemic effects. The FASEB Journal. 2025;39(4). doi:10.1096/fj.202402780r
BibTeX
@article{Adams2025,
author = {Adams, Lauren and Rasid, Orhan and Hulme, Heather and Quon, Tezz and Burchmore, Richard and Milling, Simon and Goodwin, Richard J A and Wall, Daniel M},
title = {Spatial mapping of dextran sodium sulphate‐induced intestinal inflammation and its systemic effects},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {4},
doi = {10.1096/fj.202402780r}
}
EUVIMED